China Botulinum Toxin Market Forecast 2023-2030

The China botulinum toxin market is set to record a 10.31% CAGR during the forecast period, 2023-2030. Growing demand for botulinum toxin for medical and cosmetic purposes is driving the market growth in China.

MARKET INSIGHTS

Botulinum toxin has been proven effective in reducing headache frequency and severity, making it a popular treatment for chronic migraine in China. The prevalence of migraine is high, especially among the population aged between 40 and 49, which is expected to drive demand for botulinum toxin in the country.

The cosmetic use of botulinum toxin is also on the rise in China, with only two products currently cleared for marketing in the country. However, with new market players seeking to enter the Chinese market, the industry is expected to expand. For instance, Galderma received approval for Restylane products from the National Medical Products Administration in China in 2020, allowing for expanding the Restylane portfolio in the country.

As more market players emerge in China, the industry is anticipated to grow further. It presents opportunities for new players to enter the market and compete with established players. However, the country's regulatory challenges may constrain the market's growth during the forecast period. The rising demand for botulinum toxin for medical and cosmetic purposes in China is expected to drive market growth in the coming years.

COMPETITIVE INSIGHTS

Some of the prominent market players include Daewoong Pharmaceutical Co Ltd, AbbVie, Lanzhou Institute of Biological Products Co Ltd, Galderma, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 38844

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
- 2.5.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
2.6. MAJOR MARKET FINDINGS
- 2.6.1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
- 2.6.2. GROWING AWARENESS ABOUT 'NOTOX'
- 2.6.3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
- 3.1.2. RISING GERIATRIC POPULATION
- 3.1.3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
3.2. KEY RESTRAINTS
- 3.2.1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
- 3.2.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
4.2. PESTLE ANALYSIS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
- 4.4.1. GROWTH PROSPECT MAPPING FOR CHINA
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TYPE

5.1. TYPE A BOTULINUM TOXIN
5.2. TYPE B BOTULINUM TOXIN

6. MARKET BY USER DEMOGRAPHIC

6.1. WOMEN
6.2. MEN

7. MARKET BY APPLICATION

7.1. MEDICAL
- 7.1.1. CHRONIC MIGRAINE
- 7.1.2. MUSCLE SPASM
- 7.1.3. OVERACTIVE BLADDER
- 7.1.4. HYPERHIDROSIS
- 7.1.5. OTHER MEDICAL APPLICATIONS
7.2. AESTHETIC
- 7.2.1. CROW'S FEET
- 7.2.2. FOREHEAD LINES
- 7.2.3. FROWN LINES/GLABELLAR
- 7.2.4. SQUARE JAW/MASSETER
- 7.2.5. OTHER AESTHETIC APPLICATIONS

8. MARKET BY END-USER

8.1. SPECIALTY AND DERMATOLOGY CLINICS
8.2. HOSPITALS AND CLINICS
8.3. OTHER END-USERS

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS
- 9.1.4. BUSINESS EXPANSIONS
9.2. COMPANY PROFILES
- 9.2.1. ABBVIE
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT LIST
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. DAEWOONG PHARMACEUTICAL CO LTD
  - 9.2.2.1. COMPANY PROFILE
  - 9.2.2.2. PRODUCT LIST
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. EVOLUS INC
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT LIST
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. GALDERMA
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT LIST
  - 9.2.5.3. STRENGTHS & CHALLENGES

Product Code: 38844

LIST OF TABLES

TABLE 1: CHINA MARKET SNAPSHOT - BOTULINUM TOXIN
TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
TABLE 3: CHINA BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: CHINA BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 5: CHINA BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: CHINA BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 7: CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 9: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 11: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 13: CHINA BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: CHINA BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 15: CHINA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 16: KEY PLAYERS OPERATING IN CHINA BOTULINUM TOXIN MARKET
TABLE 17: LIST OF ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS
TABLE 20: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR CHINA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 7: CHINA BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)
FIGURE 8: CHINA BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)
FIGURE 9: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY USER DEMOGRAPHIC, IN 2022
FIGURE 10: CHINA BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2030 (IN $ MILLION)
FIGURE 11: CHINA BOTULINUM TOXIN MARKET, BY MEN, 2023-2030 (IN $ MILLION)
FIGURE 12: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 13: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
FIGURE 14: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY MEDICAL, IN 2022
FIGURE 15: CHINA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2030 (IN $ MILLION)
FIGURE 16: CHINA BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2030 (IN $ MILLION)
FIGURE 17: CHINA BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2030 (IN $ MILLION)
FIGURE 18: CHINA BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2030 (IN $ MILLION)
FIGURE 19: CHINA BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 20: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
FIGURE 21: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY AESTHETIC, IN 2022
FIGURE 22: CHINA BOTULINUM TOXIN MARKET, BY CROW'S FEET, 2023-2030 (IN $ MILLION)
FIGURE 23: CHINA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2030 (IN $ MILLION)
FIGURE 24: CHINA BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2030 (IN $ MILLION)
FIGURE 25: CHINA BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2030 (IN $ MILLION)
FIGURE 26: CHINA BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 27: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 28: CHINA BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 29: CHINA BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 30: CHINA BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)